Clinical Trials List
2008-10-01 - 2009-12-31
Phase III
Terminated10
-
Trial Applicant
Sumitomo Dainippon Pharma
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ya-Mei Bai Division of Psychiatry
- 劉英杰 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 王宗熙 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 陳高欽 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 陳震宇 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 鍾偉倫 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
120 participants
-
Global
441 participants
